"study","treatment","responders","sampleSize"
"ARISTOTLE","Apixaban_5_mg",90,9120
"ARISTOTLE","Warfarin",102,9081
"ARISTOTLE-J","Apixaban_5_mg",0,74
"ARISTOTLE-J","Warfarin",0,74
"ENGAGE AF-TIMI","Edoxaban_30_mg",169,7034
"ENGAGE AF-TIMI","Edoxaban_60_mg",133,7035
"ENGAGE AF-TIMI","Warfarin",141,7036
"J-ROCKET","Rivaroxaban_15_mg",3,637
"J-ROCKET","Warfarin",1,637
"PETRO","Dabigatran_150_mg",0,100
"PETRO","Warfarin",0,70
"RE-LY","Dabigatran_110_mg",86,6015
"RE-LY","Dabigatran_150_mg",89,6076
"RE-LY","Warfarin",63,6022
"Weitz, 2010","Edoxaban_30_mg",2,235
"Weitz, 2010","Edoxaban_60_mg",2,234
"Weitz, 2010","Warfarin",0,250
